Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer

Cancer Medicine, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2GhI02f
via IFTTT